Literature DB >> 8297138

Differential expression of extracellular matrix proteins and integrins in hepatocellular carcinoma and chronic liver disease.

K Jaskiewicz1, M R Chasen, S C Robson.   

Abstract

UNLABELLED: Extracellular matrix (ECM) molecules play an important role in the orderly development, differentiation and function of tissues. The interaction of ECM with heterodimeric transmembrane glycoproteins called integrins is thought to be an important factor in cell-cell and cell-substrate adhesions in tumours, tumour invasion and metastases.
PURPOSE: To investigate ECM and adhesion molecules in hepatocellular and breast carcinomas, chronic hepatitis and hepatic cirrhosis.
MATERIALS AND METHODS: Frozen in liquid nitrogen and also paraffin-embedded biopsies from hepatocellular adenomas (3), well-differentiated (53) and poorly differentiated (19) hepatocellular carcinomas, lobular (3) and poorly differentiated (7) breast carcinomas, chronic hepatitis (10) and hepatic cirrhosis (10) were collected and investigated. Immunohistochemical techniques were applied for the detection of ECM molecules fibronectin, laminin, tenascin, vitronectin and integrins alpha 5 and beta 4.
RESULTS: Poorer differentiation of the tumours was characterised by up-regulation of fibronectin, tenascin and vitronectin and downregulation of laminin and both integrins. These changes were observed in the interface between tumour and invaded tissues and within cancerous sinusoids.
CONCLUSION: Increased expression of some ECM glycoproteins around tumour foci suggests a role in stimulating cancer cells or a host defence mechanism accompanied by desmoplastic response to them. Downregulation of laminin in poorly differentiated tumours identifying loss of basement membrane components and parallels quantitative changes in the expression of adhesion molecules in both hepatic and breast carcinomas. This may be an important step in enhancing local invasiveness of tumour cells, facilitating tumour spreading and biological malignancy.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8297138

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  6 in total

1.  P-selectin activates integrin-mediated colon carcinoma cell adhesion to fibronectin.

Authors:  Merit E Reyes-Reyes; Margaret D George; John D Roberts; Steven K Akiyama
Journal:  Exp Cell Res       Date:  2006-09-16       Impact factor: 3.905

2.  Tenascin expression in primary and recurrent breast carcinomas and the effect of tenascin on breast tumor cell cultures.

Authors:  A M Tokés; S Paku; S Tóth; E Paál; J Kulka; J Tóth; A Telekes
Journal:  Pathol Oncol Res       Date:  2000       Impact factor: 3.201

3.  Cyr61/CCN1 displays high-affinity binding to the somatomedin B(1-44) domain of vitronectin.

Authors:  Ivo M B Francischetti; Michalis Kotsyfakis; John F Andersen; Jan Lukszo
Journal:  PLoS One       Date:  2010-02-26       Impact factor: 3.240

4.  Vitronectin in human hepatic tumours contributes to the recruitment of lymphocytes in an alpha v beta3-independent manner.

Authors:  S Edwards; P F Lalor; C Tuncer; D H Adams
Journal:  Br J Cancer       Date:  2006-11-07       Impact factor: 7.640

5.  Suppression of hepatic dysfunction in tenascin‑X‑deficient mice fed a high‑fat diet.

Authors:  Shinsaku Yamaguchi; Kohei Kawakami; Kazumi Satoh; Naoki Fukunaga; Kazuhito Akama; Ken-Ichi Matsumoto
Journal:  Mol Med Rep       Date:  2017-07-21       Impact factor: 2.952

6.  Multiplicity of fibronectin-binding alpha V integrin receptors in colorectal cancer.

Authors:  M V Agrez; R C Bates; D Mitchell; N Wilson; N Ferguson; P Anseline; D Sheppard
Journal:  Br J Cancer       Date:  1996-04       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.